doctorswithoutborders:

On April 28th, India and the EU will enter closed-door negotiations for a free trade agreement.

At stake is access to affordable medicines for millions in India and others beyond India’s borders. The country is the source of 80 percent of the AIDS medicines used in all MSF projects, and is effectively the pharmacy of the developing world.

But the signing of a free trade agreement could threaten this.

Read the full story or find out more at Campaign for Access To Essential Medicines.